Logo do repositório
 
Publicação

Artificial Intelligence in the diagnosis of dry eye

datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorEmamian, Mohammad Hassan
dc.contributor.authorAliyari, Roqayeh
dc.contributor.authorLança, Carla
dc.contributor.authorGrzybowski, Andrzej
dc.contributor.editorGrzybowski, Andrzej
dc.date.accessioned2025-12-17T10:16:13Z
dc.date.available2025-12-17T10:16:13Z
dc.date.issued2025-07
dc.description.abstractDry eye is a multifactorial disease, and its prevalence reaches 50% in some regions of the world. The disease is characterized by several signs and symptoms, and there are various diagnostic methods. However, diagnostic methods available have limitations, with some tests having poor reliability and reproducibility. So far, there is no gold standard test for diagnosing dry eye disease (DED), as there is no linear association between signs and symptoms, and often patients who have multiple signs of the disease report few symptoms or even have no symptoms. The above issues have led to difficulties in diagnosing DED. New imaging modalities, such as anterior segment optical coherence tomography (OCT), infrared meibography, in vivo confocal microscopy, tear interferometry, and non-invasive tear break-up time (TBUT), have emerged to allow objective measurements. However, the interpretation of results is based on subjective judgment. Artificial intelligence (AI) can help to solve these problems and contribute to decision-making by interpreting the results objectively. During the past years and especially after 2014, several research studies on the use of AI in the diagnosis, classification, and monitoring of DED have been published, and the results seem promising. Machine learning and deep learning methods have shown high sensitivity, specificity, and accuracy. Implementation of AI has significantly increased the speed of diagnosing DED and its causes; however, it has not yet been integrated into clinical practice. AI will play an important role in diagnosing and managing dry eye soon. AI can also be used for analysis of big data, which may predict estimates of DED prevalence and its risk factors. This will be a big step to identify individual risk factors for upscaling precision medicine in DED.eng
dc.identifier.citationEmamian MH, Aliyari R, Lança C, Grzybowski A. Artificial Intelligence in the diagnosis of dry eye. In: Grzybowski A, editor. Artificial Intelligence in ophthalmology. Cham: Springer; 2025. p. 333-48.
dc.identifier.doi10.1007/978-3-031-83756-2_24
dc.identifier.isbn9783031837555
dc.identifier.isbn9783031837562
dc.identifier.urihttp://hdl.handle.net/10400.21/22336
dc.language.isoeng
dc.peerreviewedyes
dc.publisherSpringer Nature Switzerland
dc.relation.hasversionhttps://link.springer.com/chapter/10.1007/978-3-031-83756-2_24
dc.relation.ispartofArtificial Intelligence in Ophthalmology
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectOphthalmology
dc.subjectDry eye disease
dc.subjectArtificial Intelligence
dc.subjectMachine learning
dc.subjectDiagnostic imaging modalities
dc.titleArtificial Intelligence in the diagnosis of dry eyeeng
dc.typebook part
dspace.entity.typePublication
oaire.citation.endPage348
oaire.citation.startPage333
oaire.citation.titleArtificial Intelligence in ophthalmology
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameLança
person.givenNameCarla
person.identifier.ciencia-id601A-6412-BF2F
person.identifier.orcid0000-0001-9918-787X
relation.isAuthorOfPublication0320b455-ee19-4670-8bf2-10dce9de1bec
relation.isAuthorOfPublication.latestForDiscovery0320b455-ee19-4670-8bf2-10dce9de1bec

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
AI in the diagnosis of dry eye.pdf
Tamanho:
818.72 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
4.03 KB
Formato:
Item-specific license agreed upon to submission
Descrição: